Gerald de Haan

Gerald de Haan


Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2013 in Nature Reviews Immunology
Verified
Journal Article
Closed access
HGHartmut Geiger
Hartmut Geiger
GHGerald de Haan
Gerald de Haan
Maria Carolina FlorianMaria Carolina Florian
Maria Carolina Florian

21 November 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
BDBrad Dykstra
Brad Dykstra
SOSandra Olthof
Sandra Olthof
JSJaring Schreuder
Jaring Schreuder
MRMartha Ritsema
Martha Ritsema
GHGerald de Haan
Gerald de Haan
Hematopoietic stem cell (HSC) populations change with aging, but the extent to which this is caused by qualitative versus quantitative alterations in HSC subtypes is unclear. Using clonal assays, in this study we show that the aging HSC compartment undergoes both quantitative and qualitative changes. We observed a variable increase of HSC pool size with age, accompanied by the accumulation of predominantly myeloid-biased HSCs that regenerate substantially fewer mature progeny than young myeloid-biased HSCs and exhibit reduced self-renewal activity as measured by long-term secondary transplantation. Old HSCs had a twofold reduction in marrow-homing efficiency and a similar decrease in functional frequency as measured using long-term transplantation assays. Similarly, old HSCs had a twofold reduced seeding efficiency and a significantly delayed proliferative response compared with young HSCs in long-term stromal cell co-cultures but were indistinguishable in suspension cultures. We show that these functional defects are characteristics of most or all old HSCs and are not indicative of a nonfunctional subset of cells that express HSC markers. Furthermore, we demonstrate that cells with functional properties of old HSCs can be generated directly from young HSCs by extended serial transplantation, which is consistent with the possibility that they arise through a process of cellular aging.

30 April 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ILIsabelle M. A. Lombaert
Isabelle M. A. Lombaert
JBJeanette F. Brunsting
Jeanette F. Brunsting
PWPieter K. Wierenga
Pieter K. Wierenga
HFHette Faber
Hette Faber
MSMonique A. Stokman
Monique A. Stokman
RCRob P. Coppes
Rob P. Coppes
Head and neck cancer is the fifth most common malignancy and accounts for 3% of all new cancer cases each year. Despite relatively high survival rates, the quality of life of these patients is severely compromised because of radiation-induced impairment of salivary gland function and consequential xerostomia (dry mouth syndrome). In this study, a clinically applicable method for the restoration of radiation-impaired salivary gland function using salivary gland stem cell transplantation was developed. Salivary gland cells were isolated from murine submandibular glands and cultured in vitro as salispheres, which contained cells expressing the stem cell markers Sca-1, c-Kit and Musashi-1. In vitro, the cells differentiated into salivary gland duct cells and mucin and amylase producing acinar cells. Stem cell enrichment was performed by flow cytrometric selection using c-Kit as a marker. In vitro, the cells differentiated into amylase producing acinar cells. In vivo, intra-glandular transplantation of a small number of c-Kit+ cells resulted in long-term restoration of salivary gland morphology and function. Moreover, donor-derived stem cells could be isolated from primary recipients, cultured as secondary spheres and after re-transplantation ameliorate radiation damage. Our approach is the first proof for the potential use of stem cell transplantation to functionally rescue salivary gland deficiency.

1 February 2018 in Blood
Verified
Journal Article
Closed access
PDF file
GHGerald de Haan
Gerald de Haan
SLSeka Simone Lazare
Seka Simone Lazare
Hematopoietic stem cells (HSCs) ensure a balanced production of all blood cells throughout life. As they age, HSCs gradually lose their self-renewal and regenerative potential, whereas the occurrence of cellular derailment strongly increases. Here we review our current understanding of the molecular mechanisms that contribute to HSC aging. We argue that most of the causes that underlie HSC aging result from cell-intrinsic pathways, and reflect on which aspects of the aging process may be reversible. Because many hematological pathologies are strongly age-associated, strategies to intervene in aspects of the stem cell aging process may have significant clinical relevance.

13 February 2005 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
LBLeonid Bystrykh
Leonid Bystrykh
EWEllen Weersing
Ellen Weersing
BDBert Dontje
Bert Dontje
SSSue Sutton
Sue Sutton
MPMathew T Pletcher
Mathew T Pletcher
GHGerald de Haan
Gerald de Haan

1 March 2006 in Blood
Verified
Journal Article
Closed access
PDF file
LKLeonie Kamminga
Leonie Kamminga
LBLeonid V. Bystrykh
Leonid V. Bystrykh
ABAletta de Boer
Aletta de Boer
SHSita Houwer
Sita Houwer
JDJosé Douma
José Douma
GHGerald de Haan
Gerald de Haan
The molecular mechanism responsible for a decline of stem cell functioning after replicative stress remains unknown. We used mouse embryonic fibroblasts (MEFs) and hematopoietic stem cells (HSCs) to identify genes involved in the process of cellular aging. In proliferating and senescent MEFs one of the most differentially expressed transcripts was Enhancer of zeste homolog 2 (Ezh2), a Polycomb group protein (PcG) involved in histone methylation and deacetylation. Retroviral overexpression of Ezh2 in MEFs resulted in bypassing of the senescence program. More importantly, whereas normal HSCs were rapidly exhausted after serial transplantations, overexpression of Ezh2 completely conserved long-term repopulating potential. Animals that were reconstituted with 3 times serially transplanted control bone marrow cells all died due to hematopoietic failure. In contrast, similarly transplanted Ezh2-overexpressing stem cells restored stem cell quality to normal levels. In a “genetic genomics” screen, we identified novel putative Ezh2 target or partner stem cell genes that are associated with chromatin modification. Our data suggest that stabilization of the chromatin structure preserves HSC potential after replicative stress.